"Inactive" ingredients in oral medications.

Reker, Daniel; Blum, Steven M; Steiger, Christoph; Anger, Kevin E; Sommer, Jamie M; Fanikos, John; Traverso, Giovanni

Reker, Daniel; Blum, Steven M; Steiger, Christoph; Anger, Kevin E; Sommer, Jamie M; Fanikos, John; Traverso, Giovanni.

Afiliación

Reker D; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Blum SM; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Steiger C; MIT-IBM Watson AI Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Anger KE; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Sommer JM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Fanikos J; Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Traverso G; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Sci Transl Med ; 11(483)2019 03 13.

Article en En | MEDLINE | ID: mdl-30867323

Asunto(s)

Preparaciones Farmacéuticas/administración & dosificación; Preparaciones Farmacéuticas/análisis; Administración Oral; Animales; Composición de Medicamentos; Excipientes/efectos adversos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas Límite: Animals / Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google